Tobias Laich

Title: Tobias Laich: Innovator in Medicament Formulation

Introduction

Tobias Laich is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of drug delivery systems. His innovative work focuses on creating medicament formulations that ensure a controlled release of active agents.

Latest Patents

Tobias Laich holds a patent for a medicament formulation that features a controlled release of an active agent. The patent describes drug formulations that include 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts and hydrates thereof. This formulation is designed to release the active compound at a defined rate, enhancing the efficacy of the medication.

Career Highlights

Throughout his career, Tobias Laich has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH, where he has contributed to various innovative projects and research initiatives.

Collaborations

Tobias has collaborated with esteemed colleagues such as Hans-Martin Siefert and Patrick Bosché. Their combined expertise has further advanced the development of effective pharmaceutical solutions.

Conclusion

Tobias Laich's contributions to medicament formulation exemplify the importance of innovation in the pharmaceutical industry. His work on controlled release formulations has the potential to significantly improve patient outcomes.